Press Ventures, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PVEN research report →
Price Chart
About the company
Press Ventures, Inc. , established in Warsaw, Poland, in 2010, possesses the exclusive Polish rights to its patented cedar leaf oil diffusion (CLO-D) technology. This innovative system works by converting cedar leaf oil into a vapor, which is then dispersed to eradicate various indoor contaminants, including bacteria, mold, and harmful viruses such as Anthrax and H1N1.
- CEO
- Edward Denkiewicz
- IPO
- 2012
- HQ
- Warsaw, IL, US
Get TickerSpark's AI analysis on PVEN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $126.00K
- P/E
- -0.10
- PEG
- -0.00
- P/S
- 0.00
- P/B
- -0.21
- EV/EBITDA
- -4.68
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 132.64%
- ROIC
- 136.31%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-26,907
- Net Income
- $-26,907+24.4%
- EPS
- $-0.00+50.0%
- OCF Growth
- -143.4%
- FCF Growth
- -143.4%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -5.12
- RSI (14)
- 17
- Avg Volume
- 88
No earnings-call transcripts are available for PVEN yet.
- Free Float
- 0.0%
- Shares Outstanding
- 12.60B
- Float Shares
- 0
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 19, 13 | Cambly Lynda | other | 270,000,000 |
| Aug 19, 13 | Denkiewicz Edward | other | 170,000,000 |
| Aug 19, 13 | BioSafety Systems Sp. z o.o. | other | 0 |
| Aug 13, 13 | Denkiewicz Edward | other | 0 |
| Apr 17, 13 | Garduque Wilson A. | other | 0 |
| Jun 18, 12 | Johnston Caroline | sell | 5,500,000 |
| Jun 18, 12 | Cambly Lynda | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our PVEN coverage
Recent articles, reports, and earnings notes.
No research on PVEN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PVEN report →